Aquatic Capital Management LLC Acadia Pharmaceuticals Inc Transaction History

Aquatic Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $983,787 - $1.71 Million	55,300 Added 120.48%	101,200 $1.87 Million
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $480,018 - $733,887	23,100 Added 101.32%	45,900 $1.44 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $475,152 - $763,116	22,800 New	22,800 $475,000
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $1.17 Million - $1.5 Million	71,600 New	71,600 $1.35 Million
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $251,158 - $325,206	17,800 New	17,800 $291,000
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $18,214 - $38,108	-1,400 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $29,316 - $38,500	1,400 New	1,400 $34,000

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.